The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans
Abstract
The vanilloid receptor TRPV1 has been identified as a molecular target for the treatment of pain associated with inflammatory diseases and cancer. Hence, TRPV1 antagonists have been considered for therapeutic evaluation in such diseases. During Phase I clinical trials with AMG 517, a highly selective TRPV1 antagonist, we found that TRPV1 blockade elicited marked, but reversible, and generally plasma concentration-dependent hyperthermia. Similar to what was observed in rats, dogs, and monkeys, hyperthermia was attenuated after repeated dosing of AMG 517 (at the highest dose tested) in humans during a second Phase I trial. However, AMG 517 administered after molar extraction (a surgical cause of acute pain) elicited long-lasting hyperthermia with maximal body temperature surpassing 40 degrees C, suggesting that TRPV1 blockade elicits undesirable hyperthermia in susceptible individuals. Mechanisms of AMG 517-induced hyperthermia were then studied in rats. AMG 517 caused hyperthermia by inducing tail skin vasoconstriction and increasing thermogenesis, which suggests that TRPV1 regulates vasomotor tone and metabolic heat production. In conclusion, these results demonstrate that: (a) TRPV1-selective antagonists like AMG 517 cannot be developed for systemic use as stand alone agents for treatment of pain and other diseases, (b) individual susceptibility influences magnitude of hyperthermia observed after TRPV1 blockade, and (c) TRPV1 plays a pivotal role as a molecular regulator for body temperature in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impaired nociception and pain sensation in mice lacking the capsaicin receptor
Caterina, M. J., Leffler, A., Malmberg, A. B., Martin, W. J., Trafton, J., Petersen-Zeitz, K. R., Koltzenburg, M., Basbaum, A. I., & Julius, D. (2000) · Science · doi:10.1126/science.288.5464.306 · Cited by 3,544
Molecular mechanisms of nociception
Julius, D., & Basbaum, A. I. (2001) · Nature · doi:10.1038/35093019 · Cited by 2,685 · cited 1×
“7), capsaicin, resiniferatoxin, components of the ‘‘inflammatory soup,” products of lipoxygenase, and G-protein coupled receptor signaling, making it a molecular integrator of pain transduction [1,14,17,29].”
BackgroundVanilloid (Capsaicin) Receptors and Mechanisms
Szallasi, A., & Blumberg, P. M. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01403-0 · Cited by 1,903
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia
Davis, J. B., Gray, J., Gunthorpe, M. J., Hatcher, J. P., Davey, P. T., Overend, P., Harries, M. H., Latcham, J., Clapham, C., Atkinson, K., et al. (2000) · Nature · doi:10.1038/35012076 · Cited by 1,760
The Vanilloid Receptor: A Molecular Gateway to the Pain Pathway
Caterina, M. J., & Julius, D. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.487 · Cited by 1,575
Ji, R.-R., Samad, T. A., Jin, S.-X., Schmoll, R., & Woolf, C. J. (2002) · Neuron · doi:10.1016/s0896-6273(02)00908-x · Cited by 1,238
The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
Szallasi, A., Cortright, D. N., Blum, C. A., & Eid, S. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2280 · Cited by 879
Thermoregulation: some concepts have changed. Functional architecture of the thermoregulatory system
Romanovsky, A. A. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00668.2006 · Cited by 786
Self-citationGavva, N. R., Tamir, R., Qu, Y., Klionsky, L., Zhang, T. J., Immke, D., Wang, J., Zhu, D., Vanderah, T. W., Porreca, F., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.079855 · Cited by 390
Self-citationSelective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain
Ghilardi, J. R., Röhrich, H., Lindsay, T. H., Sevcik, M. A., Schwei, M. J., Kubota, K., Halvorson, K. G., Poblete, J., Chaplan, S. R., Dubin, A. E., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3815-04.2005 · Cited by 384
Romanovsky, A. A., Ivanov, A. I., & Shimansky, Y. P. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01173.2001 · Cited by 351 · cited 1×
“[24] method, we found that Tas of 23–29 C were neutral for rats in this setup.”
MethodSelf-citationWalker, K. M., Urban, L., Medhurst, S. J., Patel, S., Panesar, M., Fox, A. J., & McIntyre, P. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042010 · Cited by 346
Gavva, N. R., Bannon, A. W., Surapaneni, S., Hovland, D. N., Lehto, S. G., Gore, A., Juan, T., Deng, H., Han, B., Klionsky, L., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4833-06.2007 · Cited by 315
Self-citationIncreased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus
Matthews, P. J., Aziz, Q., Facer, P., Davis, J. B., Thompson, D. G., & Anand, P. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200409000-00014 · Cited by 275
Pomonis, J. D., Harrison, J. E., Mark, L., Bristol, D. R., Valenzano, K. J., & Walker, K. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046268 · Cited by 260
Honore, P., Wismer, C. T., Mikusa, J., Zhu, C. Z., Zhong, C., Gauvin, D. M., Gomtsyan, A., El Kouhen, R., Lee, C.-H., Marsh, K., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.083915 · Cited by 253
Chizh, B. A., O’Donnell, M. B., Napolitano, A., Wang, J., Brooke, A. C., Aylott, M. C., Bullman, J. N., Gray, E. J., Lai, R. Y., Williams, P. M., et al. (2007) · Pain · doi:10.1016/j.pain.2007.06.006 · Cited by 250
Acid-Induced Pain and Its Modulation in Humans
Jones, N. G., Slater, R., Cadiou, H., McNaughton, P., & McMahon, S. B. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2619-04.2004 · Cited by 238
Steiner, A. A., Turek, V. F., Almeida, M. C., Burmeister, J. J., Oliveira, D. L., Roberts, J. L., Bannon, A. W., Norman, M. H., Louis, J.-C., Treanor, J. J. S., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1483-07.2007 · Cited by 226
Self-citationSwanson, D. M., Dubin, A. E., Shah, C., Nasser, N., Chang, L., Dax, S. L., Jetter, M., Breitenbucher, J. G., Liu, C., Mazur, C., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0495071 · Cited by 185
Troullos, E. S., Hargreaves, K. M., Butler, D. P., & Dionne, R. A. (1990) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/0278-2391(90)90007-o · Cited by 183
Gavva, N. R., Bannon, A. W., Hovland, D. N., Lehto, S. G., Klionsky, L., Surapaneni, S., Immke, D. C., Henley, C., Arik, L., Bak, A., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.125674 · Cited by 180 · cited 10×
“1 mg/kg (plasma concentration of 30 ng/ml [6] and data not shown), suggesting that hyperthermia after exposure to AMG 517 appears prior to anti-hyperalgesia in rats.”
BackgroundSelf-citationThe TRPV1 receptor and nociception
Immke, D. C., & Gavva, N. R. (2006) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2006.09.004 · Cited by 172
Self-citationKeeble, J., Russell, F., Curtis, B., Starr, A., Pinter, E., & Brain, S. D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21297 · Cited by 160
Capsaicin and central control of thermoregulation
Hori, T. (1984) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(84)90041-x · Cited by 139
Gunthorpe, M. J., Hannan, S. L., Smart, D., Jerman, J. C., Arpino, S., Smith, G. D., Brough, S., Wright, J., Egerton, J., Lappin, S. C., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.116657 · Cited by 115
Attenuated fever response in mice lacking TRPV1
Iida, T., Shimizu, I., Nealen, M. L., Campbell, A., & Caterina, M. J. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.12.007 · Cited by 108
Doherty, E. M., Fotsch, C. H., Bannon, A. W., Bo, Y. Y., Chen, N., Dominguez, C., Falsey, J. R., Gavva, N. R., Katon, J. G., Nixey, T. E., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070190p · Cited by 104
Self-citationDaily body temperature rhythm and heat tolerance in TRPV1 knockout and capsaicin pretreated mice
Szelényi, Z., Hummel, Z., Szolcsányi, J., & Davis, J. B. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03221.x · Cited by 92
Romanovsky, A. A., Sugimoto, N., Simons, C. T., & Hunter, W. S. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00757.2002 · Cited by 68
Vanilloid receptor 1 expression in human tooth pulp in relation to caries and pain.
Morgan, C. R., RODD, H. D., Clayton, N. M., Davis, J. B., & Boissonade, F. M. (2005) · PubMed · Cited by 51
Cited by
Julius, D. (2013) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101011-155833 · Cited by 1,140
Transient receptor potential channels: targeting pain at the source
Patapoutian, A., Tate, S., & Woolf, C. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2757 · Cited by 646
Wu, L.-J., Sweet, T.-B., & Clapham, D. E. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002725 · Cited by 602
Transient receptor potential channels as therapeutic targets
Moran, M. M., McAlexander, M. A., Bíró, T., & Szallasi, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3456 · Cited by 550
Advances in TRP channel drug discovery: from target validation to clinical studies
Koivisto, A.-P., Belvisi, M. G., Gaudet, R., & Szallasi, A. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00268-4 · Cited by 537
Metadata
- Authors
- Gavva, N. R., Treanor, J. J. S., Garami, A., Fang, L., Surapaneni, S., Akrami, A., Alvarez, F., Bak, A., Darling, M., Gore, A., Jang, G. R., Kesslak, J. P., Ni, L., Norman, M. H., Palluconi, G., Rose, M. J., Salfi, M., Tan, E., Romanovsky, A. A., Banfield, C., & Davar, G.
- Venue
- Pain
- Published
- 2008-05
- Volume
- 136
- Issue
- 1
- Pages
- 202-210
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2007034094
- Cited by
- 525
- References
- 31
- FWCI
- 16.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.